Despite advances in contemporary hip and knee arthroplasty, blood loss continues to be an issue. Though blood transfusion has long been used to treat post-operative anemia, the associated risks are well established. The objective of this article is to present two practical and effective approaches to minimising blood loss and transfusion rates in hip and knee arthroplasty: the use of antifibrinolytic medications such as tranexamic acid and the adoption of more conservative transfusion indications.
No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
This paper is based on a study which was presented at the Winter 2011 Current Concepts in Joint Replacement meeting in Orlando, Florida, 7th – 10th December.
- Received August 14, 2012.
- Accepted August 14, 2012.
- ©2012 British Editorial Society of Bone and Joint Surgery